Inhibitor Affinity Differs among Clinical Variants of IMP Metallo- β -Lactamases: Analysis and Implications for Inhibitor Design
ACS Infectious Diseases · 08.08.2025 · 11 (8) · 2157-2168
DOI: 10.1021/acsinfecdis.5c00138 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Infectious Diseases, online erschienen am 24.07.2025. Verfasst von Caitlyn A Thomas und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and Biochemistry, Miami University, Oxford, Ohio 45056, United States. Hauptthemen laut MEDLINE: beta-Lactamases, beta-Lactamase Inhibitors, Anti-Bacterial Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: BLRD VA, NIGMS NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry and Biochemistry, Miami University, Oxford, Ohio 45056, United States.
- Department of Molecular Biosciences, The University of Texas, Austin, Texas 78712, United States.
- Medical Service, VA Northeast Ohio Health Care System Louis Stokes Cleveland Department of Veterans Affairs Medical Center, Cleveland, Ohio 44106, United States.
- Department of Biochemistry, Case Western Reserve University, Cleveland, Ohio 45056, United States.
- Department of Medicine, Case Western Reserve University, Cleveland, Ohio 44106, United States.
- Geriatric Research, Education and Clinical Center, Louis Stokes Cleveland Department of Veterans Affairs Medical Center, Cleveland, Ohio 44106, United States.
ORCID-Profile: Caitlyn A Thomas, Thomas Smisek, Richard C Page, Robert A Bonomo, Peter Oelschlaeger, Walter Fast, Andrea N Kravats, Michael W Crowder
Förderung
- BLRD VA
- NIGMS NIH HHS
- National Institutes of Health
- Cleveland Department of Veterans Affairs
Zitieren
APA
Thomas, C. A., Alao, J. P., Smisek, T., Cheng, Z., Bethel, C. R., Yang, K., Obaseki, I., Page, R. C., Bonomo, R. A., Oelschlaeger, P., Fast, W., Kravats, A. N., & Crowder, M. W. (2025). Inhibitor Affinity Differs among Clinical Variants of IMP Metallo- β -Lactamases: Analysis and Implications for Inhibitor Design. ACS Infectious Diseases, 11(8), 2157-2168. https://doi.org/10.1021/acsinfecdis.5c00138
Vancouver
Thomas CA, Alao JP, Smisek T, Cheng Z, Bethel CR, Yang K, et al. Inhibitor Affinity Differs among Clinical Variants of IMP Metallo- β -Lactamases: Analysis and Implications for Inhibitor Design. ACS Infectious Diseases. 2025;11(8):2157-2168. doi:10.1021/acsinfecdis.5c00138
BibTeX
@article{Thomas2025,
author = {Thomas, Caitlyn A and Alao, John Paul and Smisek, Thomas and Cheng, Zishuo and Bethel, Christopher R and Yang, Kundi and Obaseki, Ikponwmosa and Page, Richard C and Bonomo, Robert A and Oelschlaeger, Peter and Fast, Walter and Kravats, Andrea N and Crowder, Michael W},
title = {Inhibitor Affinity Differs among Clinical Variants of IMP Metallo- β -Lactamases: Analysis and Implications for Inhibitor Design},
journal = {ACS Infectious Diseases},
year = {2025},
volume = {11},
number = {8},
pages = {2157--2168},
doi = {10.1021/acsinfecdis.5c00138}
}
EUVIMED